Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 34, 2023 - Issue 1
Submit an article Journal homepage
1,659
Views
5
CrossRef citations to date
0
Altmetric
Letter to the Editor

Tralokinumab rapidly improves subjective symptoms and quality of life in patients with moderate-to-severe atopic dermatitis: a real-life 16-week experience

Luigi Gargiuloa Dermatology Unit, IRCCS Humanitas Research Hospital, Milan, Italy;b Department of Biomedical Sciences, Humanitas University, Milan, ItalyView further author information
,
Luciano Ibbaa Dermatology Unit, IRCCS Humanitas Research Hospital, Milan, Italy;b Department of Biomedical Sciences, Humanitas University, Milan, ItalyCorrespondence[email protected]
View further author information
,
Carlo Alberto Vignolia Dermatology Unit, IRCCS Humanitas Research Hospital, Milan, Italy;b Department of Biomedical Sciences, Humanitas University, Milan, ItalyView further author information
,
Paola Facherisa Dermatology Unit, IRCCS Humanitas Research Hospital, Milan, ItalyView further author information
,
Mario Valentia Dermatology Unit, IRCCS Humanitas Research Hospital, Milan, Italy;b Department of Biomedical Sciences, Humanitas University, Milan, ItalyView further author information
,
Antonio Costanzoa Dermatology Unit, IRCCS Humanitas Research Hospital, Milan, Italy;b Department of Biomedical Sciences, Humanitas University, Milan, ItalyView further author information
&
Alessandra Narcisia Dermatology Unit, IRCCS Humanitas Research Hospital, Milan, ItalyView further author information
 show all
Article: 2216815 | Received 09 May 2023, Accepted 11 May 2023, Published online: 29 May 2023

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Silvia Ferrucci, Francesca Barei, Simona Tavecchio, Angelo V. Marzano, Martina Zussino, Luigi Naldi & Elena Pezzolo. (2023) Assessment of patient-reported outcomes at 24 weeks of treatment with tralokinumab for atopic dermatitis: a multicentric real-life experience. Journal of Dermatological Treatment 34:1.
Read now
Elena Pezzolo, Andrea Sechi, Jacopo Tartaglia & Luigi Naldi. (2023) A critical evaluation of suitability of tralokinumab for treatment of moderate-to-severe atopic dermatitis in adolescents and adults. Expert Review of Clinical Immunology 0:0, pages 1-12.
Read now

Articles from other publishers (3)

Luca Potestio, Cataldo PatrunoMaddalena Napolitano. (2023) Efficacy and Safety of Tralokinumab in Real Life: Possible Predictive Rapid Response Factors. Dermatitis®.
Crossref
Adaora R Ewulu, Stuti Prajapati & Steven R Feldman. (2023) The role of tralokinumab in the treatment of atopic dermatitis and future perspectives for adolescents. Immunotherapy 15:16, pages 1341-1349.
Crossref
Francesca Caroppo & Anna Belloni Fortina. (2023) Real‐life case‐series experience with tralokinumab in patients with severe atopic dermatitis. JEADV Clinical Practice.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.